EDGAR·FLOW

Lantern Pharma Inc. — Form 10-Q

Filed November 17, 2026 · analyzed by the Periodic Agent
10-Q — Neutral significance 5/100
What the filing says
This is a standard Form 10-Q submission for Lantern Pharma Inc. for the quarter ending 2026-09-30, filed 2026-11-17. The filing header provides document structure and regulatory metadata but does not disclose specific financial results, operational changes, deal announcements, or material events within the accessible text. Detailed financials and business commentary are contained in the full 10-Q document (1.1 MB iXBRL file), which is not provided here.
Why this rating

Routine quarterly SEC filing; no concrete business information disclosed in header alone. Full filing content required to assess materiality.

View original filing on SEC.gov ↗ LTRN · stock on Yahoo Finance ↗

See more from November 17, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.